SEC FIlings

13 Sep

SEC FIlings

Registration of securities, business combinations – Amendment

November 17, 2022
Posted by Jitendra

31 Aug

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

16 Aug

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

12 Aug

SEC FIlings

Quarterly report for quarter ending June 30, 2022

November 17, 2022
Posted by Jitendra

11 Aug

SEC FIlings

Registration of securities, business combinations – Amendment

November 17, 2022
Posted by Jitendra

27 Jul

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

21 Jul

SEC FIlings

Registration of securities, business combinations – Amendment

November 17, 2022
Posted by Jitendra

07 Jul

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

05 Jul

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

05 Jul

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

Registration of securities, business combinations – Amendment

Prospectuses and communications, business combinations

Prospectuses and communications, business combinations

Quarterly report for quarter ending June 30, 2022

Registration of securities, business combinations – Amendment

Statement of acquisition of beneficial ownership by individuals

Registration of securities, business combinations – Amendment

Prospectuses and communications, business combinations

Prospectuses and communications, business combinations

Current report

Gloperba Launch – Nasdaq-2024

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Gout Awareness Day – May 22

Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch